Publicacións (41) Publicacións nas que participase algún/ha investigador/a

2007

  1. Adipokines as emerging mediators of immune response and inflammation

    Nature Clinical Practice Rheumatology, Vol. 3, Núm. 12, pp. 716-724

  2. All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 7, pp. 880-885

  3. An SNP in the 5′-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage

    Human Molecular Genetics, Vol. 16, Núm. 18, pp. 2226-2232

  4. Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe

    Genes and Immunity, Vol. 8, Núm. 2, pp. 138-146

  5. Cancer in Biopsy-Proven Giant Cell Arteritis. A Population-Based Study

    Seminars in Arthritis and Rheumatism, Vol. 37, Núm. 3, pp. 156-163

  6. Cell death and apoptosis in ostearthritic cartilage

    Current Drug Targets, Vol. 8, Núm. 2, pp. 333-345

  7. Chapter 13 Henoch-Schönlein Purpura

    Handbook of Systemic Autoimmune Diseases, Vol. 7, pp. 241-255

  8. Common Variable Immunodeficiency in Systemic Lupus Erythematosus

    Seminars in Arthritis and Rheumatism, Vol. 36, Núm. 4, pp. 238-245

  9. Consensus statement on the use of rituximab in patients with rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 2, pp. 143-150

  10. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis

    Rheumatology, Vol. 46, Núm. 3, pp. 431-434

  11. Disease pattern of spondyloarthropathies in Spain: Description of the first national registry (REGISPONSER) - Extended report

    Rheumatology, Vol. 46, Núm. 8, pp. 1309-1315

  12. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

    Arthritis Care and Research, Vol. 57, Núm. 2, pp. 287-293

  13. Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis

    Rheumatology International, Vol. 27, Núm. 9, pp. 793-806

  14. Evidencia de mecanismos inflamatorios en la osteoartritis

    Reumatologia Clinica, Vol. 3, Núm. EXTRA 3, pp. 23-27

  15. Further evidence of the role of frizzled-related protein gene polymorphisms in osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 66, Núm. 8, pp. 1052-1055

  16. Genética en la osteoartritis

    Reumatologia Clinica, Vol. 3, Núm. EXTRA 3, pp. 13-18

  17. Giant cell arteritis in northwestern Spain: A 25-year epidemiologic study

    Medicine, Vol. 86, Núm. 2, pp. 61-68

  18. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator

    Arthritis and Rheumatism, Vol. 56, Núm. 2, pp. 555-567

  19. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 57, Núm. 1, pp. 125-132

  20. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

    Arthritis Care and Research, Vol. 57, Núm. 6, pp. 1074-1080